Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women’s Health Initiative Observational Study

BACKGROUND: In the Women’s Health Initiative (WHI) randomized trial, estrogen plus progestin increased both breast cancer incidence and mortality. In contrast, most observational studies associate estrogen plus progestin with favorable prognosis breast cancers. To address differences, a cohort of WH...

Full description

Saved in:
Bibliographic Details
Main Authors: Chlebowski, Rowan T., Manson, JoAnn E., Anderson, Garnet L., Cauley, Jane A., Aragaki, Aaron K., Stefanick, Marcia L., Lane, Dorothy S., Johnson, Karen C., Wactawski-Wende, Jean, Chen, Chu, Qi, Lihong, Yasmeen, Shagufta, Newcomb, Polly A., Prentice, Ross L.
Format: Artigo
Language:Inglês
Published: Oxford University Press 2013
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3691942/
https://ncbi.nlm.nih.gov/pubmed/23543779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djt043
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items